Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan Hillert

Showing results (31-40 of 306) with videos related to

Pageof 31
Sort By:
European Journal of Neurology|January 24, 2023
Observed associations between indicators of socioeconomic status and risk of multiple sclerosis in Sweden are explained by a few lifestyle-related factorsLars Alfredsson, Jan Hillert, Tomas Olsson, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 22, 2016
Re: Declines in the diagnosis of primary progressive MS-A critical change in phenotype or critical measurement error?Helga Westerlind, Leszek Stawiarz, Katharina Fink, et al.
Journal of Neuroimmunology|June 30, 2004
Expression of B-cell-activating factor of the TNF family (BAFF) and its receptors in multiple sclerosisMathula Thangarajh, Andreia Gomes, Thomas Masterman, et al.
BMC Bioinformatics|July 31, 2020
A topological data analysis based classification method for multiple measurementsHenri Riihimäki, Wojciech Chachólski, Jakob Theorell, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|April 29, 2024
Coronavirus disease 2019 infection among working-aged people with multiple sclerosis and the impact of disease-modifying therapiesChantelle Murley, Emma Pettersson, Jan Hillert, et al.
Scientific Reports|September 18, 2021
Cerebrospinal fluid markers in incident pediatric-onset multiple sclerosis: a nationwide studyKyla A McKay, Ronny Wickström, Jan Hillert, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|December 20, 2024
Sick leave in the prodromal phase of multiple sclerosis and its association with diagnostic delay: A short reportAlejandra Machado, Emma Pettersson, Kristina Alexanderson, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 2, 2021
Increased rate of hospitalisation for COVID-19 among rituximab-treated multiple sclerosis patients: A study of the Swedish multiple sclerosis registryTim Spelman, Lars Forsberg, Kyla McKay, et al.
Neurogenetics|October 10, 2008
Risk for multiple sclerosis in relatives and spouses of patients diagnosed with autoimmune and related conditionsKari Hemminki, Xinjun Li, Jan Sundquist, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|October 28, 2020
Importance of early treatment decisions on future income of multiple sclerosis patientsAndrius Kavaliunas, Ali Manouchehrinia, Hanna Gyllensten, et al.
Pageof 31

Showing results (31-40 of 306) with videos related to

Sort By:
Pageof 31
European Journal of Neurology|January 24, 2023
Observed associations between indicators of socioeconomic status and risk of multiple sclerosis in Sweden are explained by a few lifestyle-related factorsLars Alfredsson, Jan Hillert, Tomas Olsson, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 22, 2016
Re: Declines in the diagnosis of primary progressive MS-A critical change in phenotype or critical measurement error?Helga Westerlind, Leszek Stawiarz, Katharina Fink, et al.
Journal of Neuroimmunology|June 30, 2004
Expression of B-cell-activating factor of the TNF family (BAFF) and its receptors in multiple sclerosisMathula Thangarajh, Andreia Gomes, Thomas Masterman, et al.
BMC Bioinformatics|July 31, 2020
A topological data analysis based classification method for multiple measurementsHenri Riihimäki, Wojciech Chachólski, Jakob Theorell, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|April 29, 2024
Coronavirus disease 2019 infection among working-aged people with multiple sclerosis and the impact of disease-modifying therapiesChantelle Murley, Emma Pettersson, Jan Hillert, et al.
Scientific Reports|September 18, 2021
Cerebrospinal fluid markers in incident pediatric-onset multiple sclerosis: a nationwide studyKyla A McKay, Ronny Wickström, Jan Hillert, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|December 20, 2024
Sick leave in the prodromal phase of multiple sclerosis and its association with diagnostic delay: A short reportAlejandra Machado, Emma Pettersson, Kristina Alexanderson, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 2, 2021
Increased rate of hospitalisation for COVID-19 among rituximab-treated multiple sclerosis patients: A study of the Swedish multiple sclerosis registryTim Spelman, Lars Forsberg, Kyla McKay, et al.
Neurogenetics|October 10, 2008
Risk for multiple sclerosis in relatives and spouses of patients diagnosed with autoimmune and related conditionsKari Hemminki, Xinjun Li, Jan Sundquist, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|October 28, 2020
Importance of early treatment decisions on future income of multiple sclerosis patientsAndrius Kavaliunas, Ali Manouchehrinia, Hanna Gyllensten, et al.
Pageof 31